Pony AI Inc. (HKG:2026)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
61.55
+1.00 (1.65%)
Aug 21, 2026, 4:08 PM HKT

Pony AI Earnings Call Transcripts

Fiscal Year 2026

  • Q2 2026 saw 69% revenue growth, led by an 8x surge in robotaxi revenue and strong international expansion. Operating margins and net loss improved significantly, with robust cash reserves and disciplined capital allocation supporting rapid scaling and new business launches.

  • Q1 2026 saw 145% revenue growth, record robotaxi adoption, and strong expansion in China and globally. Raised full-year targets for fleet size and revenue, with improved margins and robust cash reserves supporting continued investment and international growth.

Fiscal Year 2025

  • 2025 saw explosive growth with Robotaxi revenues up 160% YoY in Q4 and positive unit economics in key cities. The company targets over 3,000 vehicles and tripling revenues in 2026, leveraging global expansion, strategic partnerships, and a capital-efficient joint deployment model.

  • Q3 2025 saw 72% revenue growth, a major Hong Kong IPO, and citywide break-even for Gen-7 Robotaxi. Fleet size is set to surpass 1,000 vehicles this year and 3,000 in 2026, with strong international expansion and improved gross margins.

  • Q2 saw 76% revenue growth, driven by mass production of Gen-7 robotaxis and a 158% rise in robotaxi service revenue. User adoption surged 136% year-over-year, and the company expanded globally while maintaining strong cash reserves and focusing on scaling operations.

  • Q1 2025 saw Robotaxi revenues double year over year, with fare charging up 800% and strong global expansion through partnerships and regulatory wins. Gen 7 Robotaxi mass production begins in Q2, targeting 1,000 vehicles by year-end, while cost efficiencies and robust cash reserves support scaling.

Fiscal Year 2024

  • Reported $75M in 2024 revenue, up 4.3% year-over-year, with strong robotruck growth and expanded robotaxi operations in China's tier-one cities. Net loss widened to $275M as R&D and operating expenses rose, but mass production partnerships and regulatory approvals position the company for large-scale commercialization.